Skip to content

Rheumatoid Arthritis Patients and Porphyromonas Gingivalis

Porphyromonas Gingivalis Contribution in Rheumatoid Arthritis (RA).

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02905175
Enrollment
11
Registered
2016-09-19
Start date
2016-01-13
Completion date
2016-06-27
Last updated
2019-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

rheumatoid arthritis, Porphyromonas gingivalis

Brief summary

Rheumatoid arthritis (RA) is the most frequent joint inflammatory disease inducing joint destruction strongly correlated with anti-citrullinated protein antibodies citrullinated anti-peptide (ACPA). Precise RA etiology remained unclear with a described association between RA and periodontal disease. The missing link could be a gram-negative anaerobic bacterium called Porphyromonas gingivalis (P. gingivalis), which is heavily involved in periodontal disease and able to induce gingival citrullinated protein via an enzyme called peptidyl arginine deiminase (PAD). DNA of P. gingivalis was detected in synovial tissue and in peripheral blood mononuclear cell. To improve knowledge of P. gingivalis involvement in RA, the investigators will compare its effect on various cell type with comparison with another oral bacteria Provatella intermedia.

Interventions

PROCEDUREsynovial tissue

synoviocytes from synovial tissue

PROCEDUREblood sample

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 ans * RA or osteoarthritis with joint surgery planned * Informed consent approved and signed

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frame
Comparison of genetic signature after induction by P. gingivalis and P. intermedia on synoviocytesday 1

Secondary

MeasureTime frame
Comparison of specific transcriptome profile induced by P. gingivalis compared to P. intermedia on peripheral blood mononuclear cells (PBMC) and gingival fibroblastsday 1
Comparison of transcriptome profile between P. gingivalis and P. intermedia on RA synovial cells.day 1
Comparison of the transcriptomic profile between RA and osteoarthritis synoviocytesday 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026